The work conducted by McCulloch and Till and their colleagues, both in Canada and elsewhere, had an immediate impact. Their findings were the forerunner of the identification of a host of other stem cells in the hemopoietic system, with predictable major influence on the development of a new understanding of the blood system and then on medical care and industry.
A brief consideration of the environment in which this research was conducted provides an important lesson on the nature of discovery and innovation. The discovery of the hemopoietic stem cell represented a transformative event. In science, such epiphanies may emerge in a variety of contexts, including, by definition, the acuity and mind-set of the innovators themselves. But I believe that the academic and social context at the Ontario Cancer Institute in the late 1950s and the 1960s also played a critical role in the stem cell discovery and that certain elements of that environment should be instructive to how we think about research today, especially with respect to fostering innovation. The OCI ethos of the 1950s and 1960s was not only about venturesome science, but was also about collegiality and "freedom." For example, the collaboration between McCulloch and Till, who hardly knew each other beforehand, was sparked at one of several informal "show and tell/get acquainted" evening meetings.
McCulloch's background lay in hematology, Till's in physics, and my own (when I joined them shortly later) in genetics and cell biology. Within the OCI context, such panoplies of disciplines were seamlessly brought together to focus on one important area of investigation: cancer.
At the OCI, there was little or no concern for titles, academic discipline, or scientific specialization, nor for strategic planning, technology, and knowledge transfer-current buzzwords in the scientific commons. I recall few, if any, administrative meetings, and many other bureaucratic trappings of modern research institutions simply did not exist. Instead, the newly-minted OCI placed maximum priority on fostering a milieu encouraging scientific dialogue and interaction and, with encouragement from the management, a deep collegiality was pervasive. I do not wish to exaggerate, but this esprit was epitomized by the communal sharing of new data, of all resources, and of trainee supervision; all members of the group took great pleasure in the discoveries or advances of other individuals in the Institute and, as I recall it, without any discussion ever on publication credits. The development of the hemopoietic stem cell group was a natural consequence of this nurturing milieu.
I understand that, as pointed out by Thomas Wolfe, one cannot "go home again." It is not feasible to recreate an OCI in the modern scientific world. But to me, the McCulloch and Till stem cell discovery represents a quintessential example of the seminal importance that a free and friendly environment plays in catalyzing paradigm-shifting science. The seeds of fertile minds bloom most effectively in appropriate soil. Any aspirations for real innovation require a serious consideration of research settings that at least approximate the OCI culture and atmosphere.
The selection of McCulloch and Till for the Lasker Award in 2005, 45 years after the initial publication of their stem cell discovery, also provides another important insight on innovation. Although these investigators received some earlier recognition for their work, including a Gairdner International Award, public acknowledgment of their discoveries was minimal prior to the 2005 Lasker Award. The new appreciation for this work, a consequence of the explosion of interest in stem cell biology in recent years, reminds us that the full impact, the "relevance" of basic science discoveries, is often not immediately apparent. Impact is often realized only when a fundamental discovery, such as multipotent stem cells, is complemented with advances in technology and knowledge over the full domain of biology. As we are all well aware, such advances have been spectacular in the past few decades and have provided the collateral knowledge underpinning the resurrection of stem cell science.
The lessons epitomized by the McCulloch and Till story are clear. The hemopoietic stem cell discoveries were transformative in the 1950s and 1960s, but their potential benefits to society are only starting to be appreciated four decades later and are likely to become even more apparent in the context of 21st-century biological science.
These discoveries arose in an ambience of cooperation and openness. They emerged from a pure desire to "know," and from classic scientific endeavor in the absence of demand to demonstrate relevance, speculate on benefit, transfer knowledge, strategize, commercialize, and prioritize. As we delight in the recognition of this science from the past, one can only hope that this award can be transformative to the science culture of the present. While it is the obvious longterm goal of biomedical research, translation of scientific endeavors to societal benefit is often elusive, cannot be mandated nor easily predicted, and will be lost in a managed science culture that favors immediate impact over real biological innovation.
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